AC
SRRA

AWH Capital’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

AWH Capital’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-5,000
Closed -$414K – 17
2018
Q1 		$414K Sell
5,000
-12,125
-71% -$1.37M 0.47% 15
2017
Q4 		$2.56M Buy
+17,125
New +$1.65M 2.26% 16

Other funds holding SRRA

FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Perceptive Advisors
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

AWH Capital's SRRA Position: Q2 2018 in Review

AWH Capital sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q2 2018, closing a stake of 5,000 shares — an estimated $414K sold.

AWH Capital first reported a position in SRRA in Q4 2017 and held it in 2 quarters. The position peaked at $2.56M in Q4 2017. 70 funds tracked by Wall St. Rank hold SRRA as of Q2 2018.

  • AWH Capital reported no remaining Sierra Oncology, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
  • AWH Capital sold 5,000 Sierra Oncology, Inc. Common Stock shares in Q2 2018, an estimated $414K.
  • AWH Capital first reported a position in Sierra Oncology, Inc. Common Stock in Q4 2017 and held it in 2 quarters.
  • AWH Capital's Sierra Oncology, Inc. Common Stock position peaked at $2.56M in Q4 2017.
  • 70 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q2 2018.

Based on AWH Capital's 13F filing for Q2 2018, filed 14 Aug 2018.